These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 37793213)

  • 1. Associations of circulating saturated long-chain fatty acids with risk of mild cognitive impairment and Alzheimer's disease in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort.
    Fan L; Borenstein AR; Wang S; Nho K; Zhu X; Wen W; Huang X; Mortimer JA; Shrubsole MJ; Dai Q;
    EBioMedicine; 2023 Nov; 97():104818. PubMed ID: 37793213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Circulating Caprylic Acid with Risk of Mild Cognitive Impairment and Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative (ADNI) Cohort.
    Fan L; Zhu X; Borenstein AR; Huang X; Shrubsole MJ; Dugan LL; Dai Q
    J Prev Alzheimers Dis; 2023; 10(3):513-522. PubMed ID: 37357292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower Serum Calcium as a Potentially Associated Factor for Conversion of Mild Cognitive Impairment to Early Alzheimer's Disease in the Japanese Alzheimer's Disease Neuroimaging Initiative.
    Sato K; Mano T; Ihara R; Suzuki K; Tomita N; Arai H; Ishii K; Senda M; Ito K; Ikeuchi T; Kuwano R; Matsuda H; Iwatsubo T; Toda T; Iwata A;
    J Alzheimers Dis; 2019; 68(2):777-788. PubMed ID: 30814351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of CSF GAP-43 and
    Zhu Y; Guo X; Zhu F; Zhang Q; Yang Y; For The Alzheimer's Disease Neuroimaging Initiative
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of mild behavioural impairment and its association with cognitive and functional impairment in normal cognition, mild cognitive impairment, and mild Alzheimer's dementia.
    Park JI;
    Psychogeriatrics; 2024 May; 24(3):555-564. PubMed ID: 38403289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex Differences in Cognitive Decline in Subjects with High Likelihood of Mild Cognitive Impairment due to Alzheimer's disease.
    Sohn D; Shpanskaya K; Lucas JE; Petrella JR; Saykin AJ; Tanzi RE; Samatova NF; Doraiswamy PM
    Sci Rep; 2018 May; 8(1):7490. PubMed ID: 29748598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting progression from mild cognitive impairment to Alzheimer's disease on an individual subject basis by applying the CARE index across different independent cohorts.
    Chen J; Chen G; Shu H; Chen G; Ward BD; Wang Z; Liu D; Antuono PG; Li SJ; Zhang Z;
    Aging (Albany NY); 2019 Apr; 11(8):2185-2201. PubMed ID: 31078129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating ethanolamine plasmalogen indices in Alzheimer's disease: Relation to diagnosis, cognition, and CSF tau.
    Kling MA; Goodenowe DB; Senanayake V; MahmoudianDehkordi S; Arnold M; Massaro TJ; Baillie R; Han X; Leung YY; Saykin AJ; Nho K; Kueider-Paisley A; Tenenbaum JD; Wang LS; Shaw LM; Trojanowski JQ; Kaddurah-Daouk RF;
    Alzheimers Dement; 2020 Sep; 16(9):1234-1247. PubMed ID: 32715599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of MRI-visible perivascular spaces with longitudinal cognitive decline across the Alzheimer's disease spectrum.
    Wang ML; Zou QQ; Sun Z; Wei XE; Li PY; Wu X; Li YH;
    Alzheimers Res Ther; 2022 Dec; 14(1):185. PubMed ID: 36514127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validating the role of the Australian National University Alzheimer's Disease Risk Index (ANU-ADRI) and a genetic risk score in progression to cognitive impairment in a population-based cohort of older adults followed for 12 years.
    Andrews SJ; Eramudugolla R; Velez JI; Cherbuin N; Easteal S; Anstey KJ
    Alzheimers Res Ther; 2017 Mar; 9(1):16. PubMed ID: 28259165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harnessing peripheral DNA methylation differences in the Alzheimer's Disease Neuroimaging Initiative (ADNI) to reveal novel biomarkers of disease.
    Vasanthakumar A; Davis JW; Idler K; Waring JF; Asque E; Riley-Gillis B; Grosskurth S; Srivastava G; Kim S; Nho K; Nudelman KNH; Faber K; Sun Y; Foroud TM; Estrada K; Apostolova LG; Li QS; Saykin AJ;
    Clin Epigenetics; 2020 Jun; 12(1):84. PubMed ID: 32539856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease.
    Zhang H; Therriault J; Kang MS; Ng KP; Pascoal TA; Rosa-Neto P; Gauthier S;
    Alzheimers Res Ther; 2018 Aug; 10(1):80. PubMed ID: 30115118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multipredictor risk models for predicting individual risk of Alzheimer's disease.
    Hou XH; Suckling J; Shen XN; Liu Y; Zuo CT; Huang YY; Li HQ; Wang HF; Tan CC; Cui M; Dong Q; Tan L; Yu JT;
    J Transl Med; 2023 Oct; 21(1):768. PubMed ID: 37904154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual rating and volumetric measurement of medial temporal atrophy in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort: baseline diagnosis and the prediction of MCI outcome.
    Varon D; Barker W; Loewenstein D; Greig M; Bohorquez A; Santos I; Shen Q; Harper M; Vallejo-Luces T; Duara R;
    Int J Geriatr Psychiatry; 2015 Feb; 30(2):192-200. PubMed ID: 24816477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychological Equivalence of the Clinical Diagnosis of Mild Cognitive Impairment in the National Alzheimer's Coordinating Center Uniform Data Set and Alzheimer's Disease Neuroimaging Initiative.
    Kiselica AM; Benge JF;
    Dement Geriatr Cogn Disord; 2021; 50(3):231-236. PubMed ID: 34186536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of the APOE ε2ε4 Genotype on the Development of Alzheimer's Disease (AD) and Mild Cognitive Impairment (MCI) in Non-Latino Whites.
    Ren D; Lopez OL; Lingler JH; Conley Y
    J Am Geriatr Soc; 2020 May; 68(5):1044-1049. PubMed ID: 32017008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
    Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
    Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificially low mild cognitive impairment to normal reversion rate in the Alzheimer's Disease Neuroimaging Initiative.
    Thomas KR; Eppig JS; Weigand AJ; Edmonds EC; Wong CG; Jak AJ; Delano-Wood L; Galasko DR; Salmon DP; Edland SD; Bondi MW;
    Alzheimers Dement; 2019 Apr; 15(4):561-569. PubMed ID: 30610833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic classification of mild cognitive impairment and Alzheimer's disease: MRI independent component analysis.
    Willette AA; Calhoun VD; Egan JM; Kapogiannis D;
    Psychiatry Res; 2014 Nov; 224(2):81-8. PubMed ID: 25194437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
    Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
    Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.